Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 25 studies | 32% ± 16% | |
astrocyte | 16 studies | 45% ± 20% | |
oligodendrocyte | 15 studies | 43% ± 18% | |
oligodendrocyte precursor cell | 13 studies | 42% ± 20% | |
fibroblast | 13 studies | 23% ± 8% | |
microglial cell | 11 studies | 26% ± 10% | |
epithelial cell | 10 studies | 34% ± 16% | |
GABAergic neuron | 9 studies | 40% ± 21% | |
glutamatergic neuron | 9 studies | 44% ± 22% | |
adipocyte | 9 studies | 42% ± 12% | |
ciliated cell | 9 studies | 26% ± 9% | |
epithelial cell of proximal tubule | 8 studies | 35% ± 11% | |
macrophage | 8 studies | 28% ± 12% | |
basal cell | 8 studies | 31% ± 17% | |
retinal cone cell | 7 studies | 36% ± 10% | |
plasma cell | 6 studies | 27% ± 12% | |
neuron | 6 studies | 39% ± 19% | |
interneuron | 6 studies | 49% ± 25% | |
retinal rod cell | 6 studies | 24% ± 5% | |
type I pneumocyte | 6 studies | 25% ± 7% | |
type II pneumocyte | 6 studies | 20% ± 5% | |
cardiac muscle cell | 5 studies | 24% ± 3% | |
endothelial cell of lymphatic vessel | 5 studies | 26% ± 5% | |
hepatocyte | 5 studies | 46% ± 19% | |
club cell | 5 studies | 19% ± 5% | |
kidney loop of Henle epithelial cell | 4 studies | 22% ± 5% | |
natural killer cell | 4 studies | 17% ± 2% | |
granule cell | 4 studies | 25% ± 8% | |
retinal bipolar neuron | 4 studies | 21% ± 3% | |
mesothelial cell | 4 studies | 28% ± 15% | |
vein endothelial cell | 4 studies | 28% ± 15% | |
Mueller cell | 4 studies | 29% ± 5% | |
connective tissue cell | 4 studies | 22% ± 4% | |
goblet cell | 4 studies | 26% ± 14% | |
myofibroblast cell | 4 studies | 21% ± 6% | |
smooth muscle cell | 4 studies | 21% ± 4% | |
pericyte | 4 studies | 22% ± 4% | |
plasmablast | 3 studies | 41% ± 17% | |
GABAergic interneuron | 3 studies | 35% ± 4% | |
glial cell | 3 studies | 35% ± 6% | |
amacrine cell | 3 studies | 24% ± 5% | |
retina horizontal cell | 3 studies | 21% ± 4% | |
retinal pigment epithelial cell | 3 studies | 45% ± 27% | |
endocardial cell | 3 studies | 43% ± 8% | |
lymphocyte | 3 studies | 23% ± 8% | |
rod bipolar cell | 3 studies | 29% ± 10% | |
muscle cell | 3 studies | 36% ± 28% | |
ependymal cell | 3 studies | 51% ± 23% | |
intestinal crypt stem cell | 3 studies | 23% ± 4% | |
B cell | 3 studies | 21% ± 4% | |
T cell | 3 studies | 20% ± 1% | |
transit amplifying cell | 3 studies | 34% ± 22% | |
mast cell | 3 studies | 25% ± 4% | |
kidney distal convoluted tubule epithelial cell | 3 studies | 21% ± 6% | |
renal alpha-intercalated cell | 3 studies | 19% ± 5% | |
mucus secreting cell | 3 studies | 27% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 3444.70 | 226 / 226 | 100% | 17.99 | 406 / 406 |
esophagus | 100% | 1674.44 | 1444 / 1445 | 100% | 11.12 | 183 / 183 |
brain | 100% | 1287.23 | 2639 / 2642 | 100% | 15.10 | 705 / 705 |
prostate | 100% | 1469.69 | 245 / 245 | 100% | 16.63 | 501 / 502 |
uterus | 100% | 1558.38 | 170 / 170 | 100% | 16.11 | 458 / 459 |
ovary | 100% | 1128.87 | 180 / 180 | 100% | 12.42 | 429 / 430 |
breast | 100% | 1396.64 | 459 / 459 | 100% | 13.55 | 1114 / 1118 |
thymus | 100% | 1758.66 | 653 / 653 | 100% | 19.96 | 602 / 605 |
pancreas | 100% | 1224.51 | 328 / 328 | 99% | 12.73 | 177 / 178 |
kidney | 100% | 4054.39 | 89 / 89 | 99% | 17.88 | 892 / 901 |
lung | 99% | 1019.91 | 572 / 578 | 100% | 12.17 | 1152 / 1155 |
bladder | 100% | 1396.29 | 21 / 21 | 99% | 13.26 | 497 / 504 |
skin | 100% | 1337.62 | 1806 / 1809 | 99% | 16.81 | 466 / 472 |
intestine | 100% | 1734.97 | 966 / 966 | 98% | 13.98 | 519 / 527 |
stomach | 100% | 1206.73 | 358 / 359 | 98% | 12.68 | 281 / 286 |
adrenal gland | 100% | 5101.27 | 258 / 258 | 95% | 9.94 | 218 / 230 |
lymph node | 0% | 0 | 0 / 0 | 100% | 13.20 | 29 / 29 |
spleen | 100% | 1194.01 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 14.76 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 8.72 | 1 / 1 |
adipose | 100% | 1399.92 | 1202 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 1312.93 | 799 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 1519.68 | 1325 / 1335 | 0% | 0 | 0 / 0 |
heart | 94% | 1219.29 | 813 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 84% | 6.99 | 67 / 80 |
peripheral blood | 49% | 515.60 | 452 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006574 | Biological process | valine catabolic process |
GO_0009083 | Biological process | branched-chain amino acid catabolic process |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005739 | Cellular component | mitochondrion |
GO_0016787 | Molecular function | hydrolase activity |
GO_0003860 | Molecular function | 3-hydroxyisobutyryl-CoA hydrolase activity |
Gene name | HIBCH |
Protein name | 3-hydroxyisobutyryl-CoA hydrolase 3-hydroxyisobutyryl-CoA hydrolase (HIB-CoA hydrolase) (HIBYL-CoA-H) (EC 3.1.2.4) (3-hydroxyisobutyryl-coenzyme A hydrolase) 3-hydroxyisobutyryl-CoA hydrolase (EC 3.1.2.4) 3-hydroxyisobutyryl-CoA hydrolase, mitochondrial (EC 3.1.2.4) (3-hydroxyisobutyryl-coenzyme A hydrolase) (HIB-CoA hydrolase) (HIBYL-CoA-H) |
Synonyms | |
Description | FUNCTION: Hydrolyzes 3-hydroxyisobutyryl-CoA (HIBYL-CoA), a saline catabolite. Has high activity toward isobutyryl-CoA. Could be an isobutyryl-CoA dehydrogenase that functions in valine catabolism. Also hydrolyzes 3-hydroxypropanoyl-CoA. . FUNCTION: Hydrolyzes 3-hydroxyisobutyryl-CoA (HIBYL-CoA), a saline catabolite. Has high activity toward isobutyryl-CoA. Could be an isobutyryl-CoA dehydrogenase that functions in valine catabolism. Also hydrolyzes 3-hydroxypropanoyl-CoA. . FUNCTION: Hydrolyzes 3-hydroxyisobutyryl-CoA (HIBYL-CoA), a saline catabolite. Has high activity toward isobutyryl-CoA. Could be an isobutyryl-CoA dehydrogenase that functions in valine catabolism. Also hydrolyzes 3-hydroxypropanoyl-CoA. . FUNCTION: Hydrolyzes 3-hydroxyisobutyryl-CoA (HIBYL-CoA), a saline catabolite. Has high activity toward isobutyryl-CoA. Could be an isobutyryl-CoA dehydrogenase that functions in valine catabolism. Also hydrolyzes 3-hydroxypropanoyl-CoA. . FUNCTION: Hydrolyzes 3-hydroxyisobutyryl-CoA (HIBYL-CoA), a saline catabolite. Has high activity toward isobutyryl-CoA. Could be an isobutyryl-CoA dehydrogenase that functions in valine catabolism. Also hydrolyzes 3-hydroxypropanoyl-CoA. . |
Accessions | H7C126 ENST00000409934.1 B8ZZZ0 ENST00000399855.2 ENST00000359678.10 [Q6NVY1-1] ENST00000392332.7 [Q6NVY1-2] B9A058 ENST00000410045.5 ENST00000416732.5 ENST00000409820.2 ENST00000392333.7 H7BYI7 F8W8A6 H7C1A5 Q6NVY1 |